67413-26-7Relevant articles and documents
COVALENT RAS INHIBITORS AND USES THEREOF
-
, (2021/06/04)
The disclosure features compounds, or pharmaceutically acceptable salts thereof, alone and in combination with other therapeutic agents, pharmaceutical compositions, and protein conjugates thereof, capable of modulating biological processes including Ras, and their uses in the treatment of cancers.
Selective cleavage of carbamate protecting groups from aziridines with otera's catalyst
Sun, Shan,Tirotta, Ilaria,Zia, Nicholas,Hutton, Craig A.
, p. 411 - 415 (2014/04/03)
Otera's distannoxane catalyst was found to promote the cleavage of carbamate groups from N-protected aziridines. This method enables the chemoselective cleavage of an aziridinyl N-carbobenzyloxy (Cbz) group in the presence of other N-Cbz groups. The selec
An expeditious in situ preparation of benzyl (S)-2-aziridinecarboxylate
Kuyl-Yeheskiely, E.,Dreef-Tromp, C. M.,Marel, G. A. van der,Boom, J. H. van
, p. 314 - 316 (2007/10/02)
The use of diethoxytriphenylphosphorane in the preparation of benzyl (S)-2-aziridinecarboxylate is illustrated.The latter compound has been coupled with Z-Ala-OH and the aziridine dipeptide thus obtained ring-opened via C-3-N-1 cleavage with benzyl alcoho